CAJ | 학술논문

目的：探究冠心病患者接受不同药物治疗的临床效果，为以后治疗此类患者提供可靠参考数据。方法：对本院近年来收治冠心病患者80例进行回顾性分析，根据药物差异将其分为a组与B组，每组均有患者40例。a组患者在常规治疗基础上应用泰嘉，B组患者在常规治疗基础上应用波利维。对比2组患者临床疗效及并发症情况。结果：相对于a组患者，B组患者临床疗效更具优越性，差异有统计学意义（P<0.05）；对2组患者进行平均时间为6个月的随访，B组患者出现心肌梗死、心力衰竭等心脑血管事件显著低于a组，差异有统计学意义（P<0.05）。结论：冠心病患者在常规治疗基础上联合波利维，相对于联合泰嘉临床治疗效果更突出，降低治疗后心脑血管发生概率，具有高效安全的优点，值得临床普及推广。
목적：탐구관심병환자접수불동약물치료적림상효과，위이후치료차류환자제공가고삼고수거。방법：대본원근년래수치관심병환자80례진행회고성분석，근거약물차이장기분위a조여B조，매조균유환자40례。a조환자재상규치료기출상응용태가，B조환자재상규치료기출상응용파리유。대비2조환자림상료효급병발증정황。결과：상대우a조환자，B조환자림상료효경구우월성，차이유통계학의의（P<0.05）；대2조환자진행평균시간위6개월적수방，B조환자출현심기경사、심력쇠갈등심뇌혈관사건현저저우a조，차이유통계학의의（P<0.05）。결론：관심병환자재상규치료기출상연합파리유，상대우연합태가림상치료효과경돌출，강저치료후심뇌혈관발생개솔，구유고효안전적우점，치득림상보급추엄。
Objective: to explore the clinical effect of receiving drug treatment in patients with coronary heart disease, provide a reliable reference data for future treatment of such patients.Methods: in coronary heart disease patients admitted to our hospital in recent years retrospective analysis of 80 cases, according to drug difference divided into group a and group b, there were 40 cases in each group. application of plavix patients routine treatment of group a, group b patients in the conventional treatment based on the Tiger. Comparative clinical efifcacy and complications of 2 groups of patients.Result: with respect to a group of patients, clinical therapeutic effects of more superiority in Group b, there was a statistically signiifcant difference (P<0.05), on 2 groups of patients for an average of 6 months of follow up, group b in patients with myocardial infarction, heart failure and other cardiovascular events were significantly lower than a group, a statistically significant difference (P<0.05). Conclusion: on the basis of conventional therapy in patients with coronary heart disease combined, in the consolidated plavix clinical effects are more prominent, reduce the probability of treatment of cardio-cerebral vascular, has the advantages of high efifciency, worthy of popularization.